|
MEDI-FUTURE, Inc. is a global healthcare company that strives to improve the quality of life of women around the world by dedicating itself exclusively to women’s breast care.
MEDI-FUTURE’s core products focus on breast cancer prevention and include Brestige, a full field digital mammography system that utilizes a flat panel detector and innovative image processing technology; MammoVU, a dedicated radiologist review workstation with complete functionality and streamlined workflow; and LeadStereo, high-precision stereotactic biopsy system designed for use with Brestige. Technologies in development include tomosynthesis and dense-breast-optimized CAD.
Digital Mammography System
Brestige is a full-field digital mammography system used for screening and diagnosing breast cancer, able to rapidly acquire images of superb quality and maintain low doses of radiation. With its high dynamic range and innovative image processing technology, Brestige's high-contrast images are especially suited for patients with smaller, denser breasts, such as Asian women. In addition to the system's highly efficient workflow, Brestige is also designed to minimize patient discomfort with its soft, slim design. Brestige has received various certifications and awards, including ISO 13485, CE, SFDA, KFDA, GOST-R, TaiwanFDA, World-Class Product Award, Good Design Award and Columbus Project Award.
Stereotactic Needle Guidance Device
The LeadStereo is Stereotactic Needle Guidance Device guided by MEDIFUTURE’s digital mammography, Brestige. It can detect micro-calcifications and minute lesions not visible with ultrasound, eliminating the need for surgery.
A stereotactic biopsy is less invasive, more convenient and simpler procedure for assessing a breast abnormality than open surgical biopsy. The biopsy add-on has a micro-processor controlled, motor-driven needle guide in three orthogonal planes and can be used in conjunction with Brestige to provide automatic, precise stereotactical location of a biopsy needle in any
region of interest that is perceptible on a Brestige.
With the LeadStereo system, users can perform stereotactic procedures safely and quickly while providing accurate targeting regardless of breast thickness or breast lesion location. To accurately reach the lesion, one Scout View image (at 0°) and two Stereo View images (at ±15° from center) are taken in angulation mode, after which the target lesion is selected and its x, y, z coordinates are calculated.
- Stage Movement : Motorized
- Stereotactic Angle : ±15°
- Available to all breast thickness
|
